Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Mastboom

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
The Bone & Joint Journal|March 1, 2019
The effect of surgery in tenosynovial giant cell tumours as measured by patient-reported outcomes on quality of life and joint functionF G M Verspoor, M J L Mastboom, G Hannink, et al.
Journal of Surgical Oncology|June 23, 2022
Surgical management of 144 diffuse-type TGCT patients in a single institution: A 20-year cohort studyGeert Spierenburg, Lizz van der Heijden, Monique J L Mastboom, et al.
The Bone & Joint Journal|April 1, 2021
Management of tenosynovial giant cell tumour of the foot and ankleGeert Spierenburg, Sarah Tamar Lancaster, Lizz van der Heijden, et al.
Surgical Oncology|September 15, 2020
The effect of Imatinib Mesylate in diffuse-type Tenosynovial Giant Cell Tumours on MR imaging and PET-CTM J L Mastboom, W Lips, K van Langevelde, et al.
Surgical Oncology|September 16, 2018
Severity classification of Tenosynovial Giant Cell Tumours on MR imagingM J L Mastboom, F G M Verspoor, D F Hanff, et al.
Acta Orthopaedica|August 9, 2017
Higher incidence rates than previously known in tenosynovial giant cell tumorsMonique J L Mastboom, Floortje G M Verspoor, Arjan J Verschoor, et al.
The Journal of Bone and Joint Surgery. American Volume|July 19, 2019
Surgical Treatment of Localized-Type Tenosynovial Giant Cell Tumors of Large Joints: A Study Based on a Multicenter-Pooled Database of 31 International Sarcoma CentersM J L Mastboom, E L Staals, F G M Verspoor, et al.
The Lancet. Oncology|April 29, 2019
Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort studyMonique J L Mastboom, Emanuela Palmerini, Floortje G M Verspoor, et al.
Scientific Reports|October 12, 2019
Long-term efficacy of imatinib mesylate in patients with advanced Tenosynovial Giant Cell TumorF G M Verspoor, M J L Mastboom, G Hannink, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The Bone & Joint Journal|March 1, 2019
The effect of surgery in tenosynovial giant cell tumours as measured by patient-reported outcomes on quality of life and joint functionF G M Verspoor, M J L Mastboom, G Hannink, et al.
Journal of Surgical Oncology|June 23, 2022
Surgical management of 144 diffuse-type TGCT patients in a single institution: A 20-year cohort studyGeert Spierenburg, Lizz van der Heijden, Monique J L Mastboom, et al.
The Bone & Joint Journal|April 1, 2021
Management of tenosynovial giant cell tumour of the foot and ankleGeert Spierenburg, Sarah Tamar Lancaster, Lizz van der Heijden, et al.
Surgical Oncology|September 15, 2020
The effect of Imatinib Mesylate in diffuse-type Tenosynovial Giant Cell Tumours on MR imaging and PET-CTM J L Mastboom, W Lips, K van Langevelde, et al.
Surgical Oncology|September 16, 2018
Severity classification of Tenosynovial Giant Cell Tumours on MR imagingM J L Mastboom, F G M Verspoor, D F Hanff, et al.
Acta Orthopaedica|August 9, 2017
Higher incidence rates than previously known in tenosynovial giant cell tumorsMonique J L Mastboom, Floortje G M Verspoor, Arjan J Verschoor, et al.
The Journal of Bone and Joint Surgery. American Volume|July 19, 2019
Surgical Treatment of Localized-Type Tenosynovial Giant Cell Tumors of Large Joints: A Study Based on a Multicenter-Pooled Database of 31 International Sarcoma CentersM J L Mastboom, E L Staals, F G M Verspoor, et al.
The Lancet. Oncology|April 29, 2019
Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort studyMonique J L Mastboom, Emanuela Palmerini, Floortje G M Verspoor, et al.
Scientific Reports|October 12, 2019
Long-term efficacy of imatinib mesylate in patients with advanced Tenosynovial Giant Cell TumorF G M Verspoor, M J L Mastboom, G Hannink, et al.
Pageof 2